233 companies

Travere Therapeutics

Market Cap: US$1.8b

A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.

TVTX

US$20.23

7D

-2.8%

1Y

196.6%

Alnylam Pharmaceuticals

Market Cap: US$35.2b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

ALNY

US$276.55

7D

5.1%

1Y

81.6%

Ascendis Pharma

Market Cap: US$9.8b

Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.

ASND

US$160.99

7D

-5.5%

1Y

20.2%

AVITA Medical

Market Cap: US$243.5m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

RCEL

US$9.47

7D

-2.3%

1Y

5.6%

Alkami Technology

Market Cap: US$2.8b

Provides cloud-based digital banking solutions in the United States.

ALKT

US$28.00

7D

4.9%

1Y

5.4%

Lumentum Holdings

Market Cap: US$4.5b

Manufactures and sells optical and photonic products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa.

LITE

US$66.24

7D

12.2%

1Y

55.5%

TG Therapeutics

Market Cap: US$5.5b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

TGTX

US$34.85

7D

-23.4%

1Y

103.6%

Ardelyx

Market Cap: US$945.1m

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

ARDX

US$3.70

7D

-32.8%

1Y

-56.4%

Super Micro Computer

Market Cap: US$19.7b

Develops and sells high performance server and storage solutions based on modular and open architecture in the United States, Europe, Asia, and internationally.

SMCI

US$32.48

7D

1.9%

1Y

-60.5%

Clene

Market Cap: US$24.6m

A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics.

CLNN

US$2.55

7D

-14.1%

1Y

-67.3%

Bitdeer Technologies Group

Market Cap: US$2.1b

Operates as a technology company for blockchain and computing.

BTDR

US$11.35

7D

18.6%

1Y

101.1%

CoreWeave

Market Cap: US$25.2b

Operates a cloud platform that provides scaling, support, and acceleration for GenAI.

CRWV

US$53.60

7D

29.8%

1Y

n/a

Blueprint Medicines

Market Cap: US$6.4b

A precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally.

BPMC

US$99.80

7D

11.5%

1Y

-8.3%

Core Scientific

Market Cap: US$2.7b

Provides digital asset mining services in the United States.

CORZ

US$8.90

7D

9.9%

1Y

155.7%

Applied Optoelectronics

Market Cap: US$773.9m

Designs, manufactures, and sells fiber-optic networking products in the United States, Taiwan, and China.

AAOI

US$13.98

7D

9.3%

1Y

29.1%

Red Cat Holdings

Market Cap: US$481.5m

Provides products and solutions to drone industry in the United States.

RCAT

US$5.38

7D

7.2%

1Y

352.1%

Alvotech

Market Cap: US$2.4b

Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.

ALVO

US$7.94

7D

1.3%

1Y

-41.4%

Palantir Technologies

Market Cap: US$256.9b

Palantir Technologies Inc. builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally.

PLTR

US$110.48

7D

-6.7%

1Y

412.4%

Legend Biotech

Market Cap: US$5.8b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

LEGN

US$31.47

7D

-10.0%

1Y

-31.2%

Duos Technologies Group

Market Cap: US$75.7m

Designs, develops, deploys, and operates intelligent technology solutions in North America.

DUOT

US$6.58

7D

-13.8%

1Y

114.3%

UroGen Pharma

Market Cap: US$446.7m

Engages in the development and commercialization of solutions for urothelial and specialty cancers.

URGN

US$10.12

7D

-13.1%

1Y

-23.7%

Abeona Therapeutics

Market Cap: US$279.3m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

ABEO

US$5.27

7D

-19.7%

1Y

19.7%

TruGolf Holdings

Market Cap: US$11.5m

Through its subsidiary, engages in the development and sale of indoor golf simulator hardware under the TruGolf Nevada brand for residential and commercial markets in the United States.

TRUG

US$0.27

7D

-3.1%

1Y

-83.1%

MeiraGTx Holdings

Market Cap: US$462.9m

A clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases.

MGTX

US$5.41

7D

-23.7%

1Y

5.3%

Vanda Pharmaceuticals

Market Cap: US$257.5m

A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.

VNDA

US$4.38

7D

-2.9%

1Y

-18.3%

TeraWulf

Market Cap: US$1.2b

Operates as a digital asset technology company in the United States.

WULF

US$3.05

7D

9.7%

1Y

30.9%

Nutanix

Market Cap: US$19.3b

Provides an enterprise cloud platform in North America, Europe, the Asia Pacific, the Middle East, Latin America, and Africa.

NTNX

US$73.70

7D

7.3%

1Y

11.3%

Workday

Market Cap: US$66.3b

Provides enterprise cloud applications in the United States and internationally.

WDAY

US$250.58

7D

2.3%

1Y

0.4%

OS Therapies

Market Cap: US$50.7m

A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.

OSTX

US$1.84

7D

-9.4%

1Y

n/a

Gorilla Technology Group

Market Cap: US$282.0m

Provides solutions in security, network, business intelligence, and Internet of Things (IoT) technology in the Asia Pacific region, the Americas, Cayman Islands, and internationally.

New

GRRR

US$14.85

7D

-23.7%

1Y

162.8%

Sarepta Therapeutics

Market Cap: US$4.6b

A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.

SRPT

US$36.72

7D

-41.2%

1Y

-72.3%

Capricor Therapeutics

Market Cap: US$333.4m

A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.

CAPR

US$6.89

7D

-45.7%

1Y

28.3%

Exelixis

Market Cap: US$10.2b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

EXEL

US$36.81

7D

-6.0%

1Y

70.5%

Smith Micro Software

Market Cap: US$16.4m

Develops and sells software solutions to simplify and enhance the mobile experience to wireless and cable service providers in the Americas, Europe, the Middle East, and Africa.

SMSI

US$1.05

7D

5.6%

1Y

-57.3%

Spotify Technology

Market Cap: US$129.8b

Provides audio streaming subscription services worldwide.

SPOT

US$657.10

7D

7.0%

1Y

120.0%

Zscaler

Market Cap: US$36.1b

Operates as a cloud security company worldwide.

ZS

US$233.54

7D

3.3%

1Y

36.6%

Page 1 of 7